Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing organization (CDMO) that regularly issues news on its operations, financial performance, and corporate developments. The company focuses on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets, and its updates reflect activity across these areas.
On this page, readers can follow ITGR news related to quarterly earnings, product line performance, and outlooks that Integer provides through press releases furnished with Form 8-K filings. These releases often include discussions of sales trends in Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets, along with non-GAAP financial measures such as adjusted operating income, adjusted EBITDA, adjusted net income, and adjusted earnings per share.
Integer’s news flow also covers strategic and governance events, such as leadership transitions, board appointments, and capital allocation decisions. Recent examples include the appointment of a new President and Chief Executive Officer, the election of a new director with extensive medical device industry experience, and the authorization of a share repurchase program by the Board of Directors.
In addition, Integer publishes updates on technology and market-facing activities, such as participation in medical society meetings and healthcare investor conferences. The company has highlighted innovations in neuromodulation and miniaturized active implantable medical devices, including high-performance batteries and integrated implantable pulse generator and lead systems, as well as its Xcellion Gen 3 fast charge lithium ion battery technology.
Investors and observers can use this news page to monitor how Integer communicates its strategy, product line dynamics, financing actions, and role as a CDMO in the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
Integer Holdings Corporation (NYSE: ITGR) will showcase its innovative medical device outsourcing capabilities at the MD&M West Exposition in Anaheim, California, from August 10-12, 2021. At booth #2951, Integer will highlight its advanced Xcellion® Rechargeable Batteries, which reduce charging time by up to 70% and increase runtime by 30%. The company will also present its expanded laser cutting capabilities and comprehensive lead solutions. Integer emphasizes its commitment to quality and innovation in the medical device industry.
Integer Holdings Corporation (NYSE:ITGR) reported a strong financial performance for Q2 2021, with sales increasing by 30% to $312 million. GAAP net income rose by $29 million, reaching $29 million, while non-GAAP adjusted net income surged by 239% to $36 million. The company reduced total debt by $63 million to $669 million, achieving a leverage ratio of 3.1 times adjusted EBITDA. Looking ahead, Integer has raised its full-year sales growth outlook to 12-14% and expects adjusted operating income growth between 25-36%, signaling a robust recovery from the pandemic.
Integer Holdings Corporation (NYSE:ITGR) will announce its second quarter 2021 financial results on July 29, 2021, at 7 a.m. CT. A conference call will follow at 8 a.m. CT to discuss the results and other relevant information. Investors can participate through a domestic or international dial-in and access the webcast online. The company, a leading medical device manufacturer, aims to provide innovative technologies in various medical fields. Further information and updates can be found on their investor relations website.
Integer Holdings Corporation (NYSE:ITGR) reported its Q1 2021 results, with sales of $290 million, a 12% decline from the previous year. GAAP net income fell 31% to $22 million. Despite the pandemic's impact, sales and profits showed sequential improvement compared to Q4 2020. Integer is increasing its 2021 outlook, projecting 10%-12% sales growth, along with $90 million to $110 million in free cash flow. The company's total debt decreased by $25 million to $664 million, reflecting ongoing recovery and strategic execution.
Integer Holdings Corporation (NYSE:ITGR) announces its first quarter 2021 financial results release set for April 29, 2021, at 8 a.m. ET. The management will discuss these results in a conference call at 9 a.m. ET the same day. Investors can access the call via domestic and international dial-in numbers or through a webcast. Integer is a leading medical device outsource manufacturer, focusing on various markets including cardiac and orthopedics, and will also provide updates on additional forward-looking information during the call.
Integer Holdings Corporation (NYSE:ITGR) reported strong fourth quarter results with sales of $269 million, slightly above guidance but a 17% decline year-over-year. GAAP net income rose 40% to $15 million, while adjusted net income fell 43% to $23 million. The company reduced net total debt by $123 million in 2020, ending the year with $689 million in debt. For 2021, Integer projected sales growth of 8% to 12%, with first quarter sales expected to be sequentially better than Q4 2020. The company's operational excellence strategy aims for a return to profitable growth.
Integer Holdings Corporation has elected three new directors to its Board: Sheila Antrum, Cheryl Capps, and Alvin (Tyrone) Jeffers, enhancing its manufacturing and healthcare expertise. Antrum brings over 40 years in medical operations, currently serving as COO at UCSF Health. Capps, with 35 years in supply chain management, is the SVP at Corning Inc. Jeffers, with 24 years in manufacturing, is VP of Global Manufacturing at SPX FLOW. Integer aims to leverage their diverse perspectives to drive growth and execute strategic initiatives.
Integer Holdings Corporation (NYSE:ITGR) is set to announce its financial and operational results for Q4 and full-year 2020 on February 18, 2021, at 8 a.m. ET. A conference call will follow at 9 a.m. ET, where management will discuss the results and other material information. Interested parties can participate via a domestic dial-in number or an international number. A replay of the call will be available for seven days post-event, and the call will also be accessible on the company's Investor Relations website.
Integer Holdings Corporation (NYSE: ITGR) has announced a significant expansion at its Alden, NY facility to increase production capacity for Xcellion® Lithium Ion rechargeable batteries. The expansion, which began in December 2020, aims to enhance battery production for applications in neuromodulation and cochlear devices. The project includes new manufacturing equipment and facility upgrades, expected to complete in 2021. This strategic investment is designed to meet the growing demands of Integer's cardiac and neuromodulation customers.
Integer Holdings Corporation (NYSE:ITGR) reported its third-quarter results for 2020, highlighting a sales decline of 22% to $236 million, with GAAP income down 1% to $30 million. Non-GAAP adjusted income fell 58% to $17 million, while adjusted EBITDA dropped 47% to $37 million. The company expects fourth-quarter sales to improve by $20-$35 million and projects a 200-300 basis point increase in adjusted operating income margin. Integer received a $28 million patent litigation judgment, aiding its debt reduction efforts, with net total debt decreasing to $747 million.
FAQ
What is the current stock price of Integer Hldgs (ITGR)?
What is the market cap of Integer Hldgs (ITGR)?
